SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.572-1.4%Oct 30 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (363)1/9/2014 4:06:56 PM
From: PLegee   of 368
 
Another huge step forward for Sangamo, bigger than the Shire deal in early 2012. A first tier biotech company has just validated their platform by partnering up with them and allowing a share of royalties for any market successful outcomes. Huge. Congrats Sangamo and congrats to all you long time shareholders. More monogenetic disease drug partnerships look to be possible after this huge win for SGMO. Plus, we have strong leadership on the BOD with Ringo et all; missteps are behind us, the future looks so promising.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext